skip to Main Content

EuroQol webinar series 15: Valuing EQ-5D-Y: stakeholder views on key normative issues from Canada, US and UK

You are invited to register for EuroQol webinar series 15: Valuing EQ-5D-Y: stakeholder views on key normative issues from Canada, US and UK.

Registration link:
Date and time: 15 November, 21:00-22:00 CET / 16 November, 07:00-08:00 AEDT

Brief introduction:

Valuing pediatric health related quality of life instruments such as the EQ-5D-Y raises complex methods issues. For example, whose preferences should value sets be based on – adults or children? What perspective should respondents be asked to adopt when valuing health states? There is a growing body of evidence about how these and other methods choices affect results. But the choice of approach inevitably requires value judgements.  What are the views of decision makers and other stakeholders on these issues? In this webinar we consider the findings from stakeholder engagement in three countries, and what can be learned for EQ-5D-Y value set studies.


  • Brief Introduction to the topic and speakers
    Moderator: Nancy Devlin, Younger Population Working Group; PI on QUOKKA
  • Results from stakeholder engagement in Canada
    Speaker 1: Feng Xie, McMaster University, Canada.
  • Results from stakeholder engagement in the US
    Speaker 2: Simon Pickard, University of Chicago, United States.
  • Does NICE have a position on these issues?
    Speaker 3: Oliver Rivero-Arias, University of Oxford, United Kingdom.
  • Panel discussion: All three speakers take part in a panel discussion to compare and contrast emerging evidence on value judgements relating to EQ-5D-Y valuation. Key points to be discussed will include: if views on these methods issues differ country by country, how can we ensure comparability of value sets across countries? Does the way we undertake stakeholder engagement (who we ask, and how we ask them) affect results and conclusions about methods? What does ‘best practice’ look like in stakeholder engagement? If there are a wide variety of stakeholder views within any given country, on what basis should we make methods choices? How important is comparability of values for adult EQ-5D and EQ-5D-Y values for HTA decision makers? Should we produce different EQ-5D-Y value sets for different kinds of decision-makers and applications – and if so, how can we avoid gaming? Questions from the audience are welcome.
Back To Top